Share Name Share Symbol Market Type Share ISIN Share Description
Biotech Gwth LSE:BIOG London Ordinary Share GB0000385517 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -8.50p -1.19% 708.00p 708.00p 713.50p 715.00p 707.50p 715.00p 65,305.00 16:29:50
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Equity Investment Instruments 1.8 1.1 1.3 544.6 427.29

Biotech Growth (BIOG) Latest News (1)

More Biotech Growth News
Biotech Growth Takeover Rumours

Biotech Growth (BIOG) Share Charts

1 Year Biotech Growth Chart

1 Year Biotech Growth Chart

1 Month Biotech Growth Chart

1 Month Biotech Growth Chart

Intraday Biotech Growth Chart

Intraday Biotech Growth Chart

Biotech Growth (BIOG) Discussions and Chat

Biotech Growth Forums and Chat

Date Time Title Posts
09/11/201619:43Biotech Growth Trust PLC (The)275.00

Add a New Thread

Biotech Growth (BIOG) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
17:15:06719.1315,910114,413.58O
17:01:30709.892471,753.44NT
17:00:20711.883,00021,356.40O
16:35:07708.006724,757.76UT
16:29:50708.00128906.24AT
View all Biotech Growth trades in real-time

Biotech Growth (BIOG) Top Chat Posts

DateSubject
06/12/2016
08:20
Biotech Growth Daily Update: Biotech Gwth is listed in the Equity Investment Instruments sector of the London Stock Exchange with ticker BIOG. The last closing price for Biotech Growth was 716.50p.
Biotech Gwth has a 4 week average price of 726.68p and a 12 week average price of 706.50p.
The 1 year high share price is 760p while the 1 year low share price is currently 520p.
There are currently 60,351,754 shares in issue and the average daily traded volume is 57,580 shares. The market capitalisation of Biotech Gwth is £427,290,418.32.
22/11/2014
20:58
philo124: Just read their Report and Accounts; not sure I should have sold even at these levels- looks like the story and share price has further to go in 2015.
10/4/2014
12:26
urgentclick: Looks good to me: downside recently around 409p (I picked up 1000 at that price point) and upside 550p not long ago. And the NAV comfortably exceeding the share price.
14/1/2013
00:50
yiyack3: In my experience many AIM companies are pretty well worthless, run by a CEO and a crony or two who like the good life, first class on expenses, get rich as quick as poss and don't worry when the company runs out of cash, goes bust and all the shareholders lose their investments. If an AIM company gets to be popular on the ADVFN and other bulletin boards, do what you can to hitch a ride on rising share price, then take profits and get out. Don't ever believe the story behind an AIM market share
29/7/2012
19:24
northernlass: THE QUARTER'S BEST PERFORMER Looking at individual investment portfolios, the Biotech Growth trust was the quarter's best performer in terms of both net asset value (NAV) and share price. Over the three months, its NAV rose 19.1% while share price was up 11.4% on a total return basis. Source: http://www.fundweb.co.uk/investment-trusts/news/trusts-ahead-of-open-ended-peers-despite-q2-underperformance/1053944.article
21/7/2010
17:33
chingman: Latest from Edison - The Biotech Growth Trust Plc (BIOG) has put in a respectable performance during the past 12 months, outperforming its benchmark, the NASDAQ Biotechnology Index (sterling adjusted), by 2.8% in terms of NAV total return and 3.9% in terms of share price total return. The manager believes that concerns over US healthcare reform were overdone and, while this cloud of uncertainty has lifted, concerns regarding the outlook in Europe have delayed the reversion. Looking forward, the manager considers that; biotech will be a net beneficiary of healthcare reform; the regulatory environment will continue to improve; M
26/1/2010
19:28
damanko: Ian - two is a crowd ............... I didn't bother participating in the recent fund raising, as the amount payable (ie the stated NAV) was some way north of the share price. In fact, I meant to write to the board, and ask who on earth would bother (amongst longer term holders) - when this was the case. Whatever, the institutions were keen, and the price has carried on its mild upward trend. Worth tucking away. Mind you, having bought about nine years ago, I'm now only 25% or so down on what I paid. Ho hum....
Biotech Growth share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V: D:20161206 21:54:14